ICSR (Individual Case Safety Report)
Last reviewedAn Individual Case Safety Report (ICSR) is a report of one or more suspected adverse reactions to a medicine in a single patient at a specific point in time. ICSRs are exchanged electronically between companies and regulators in the ICH E2B(R3) format.
Key facts
| Minimum information | An identifiable patient, an identifiable reporter, a suspect product and an adverse event |
|---|---|
| Electronic format | ICH E2B(R3) |
| Expedited reporting | Serious, unexpected reactions are reported as soon as possible and no later than 15 calendar days after the minimum information is first received; in clinical trials, fatal or life-threatening cases are notified within 7 calendar days |
| Contrast | An aggregate report evaluates many cases together over an interval |
How ICSRs feed aggregate reports
ICSRs are the case-level record of safety. Periodic reports such as the DSUR and PBRER draw on them, in line listings and summary tabulations, to evaluate the overall safety profile.
Sources
Read more
Part of our guide to Pharmacovigilance Aggregate Reports: DSUR, PBRER, PSUR and PADER

